相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Post-reversible cerebral vasoconstriction syndrome headache
Yu-Hsiang Ling et al.
JOURNAL OF HEADACHE AND PAIN (2021)
Characterisation of the calcitonin gene-related peptide receptor antagonists ubrogepant and atogepant in human isolated coronary, cerebral and middle meningeal arteries
Eloisa Rubio-Beltran et al.
CEPHALALGIA (2020)
Temporal Profile of Blood-Brain Barrier Breakdown in Reversible Cerebral Vasoconstriction Syndrome
Soohyun Cho et al.
STROKE (2020)
An RCVS Spectrum Disorder? New Daily Persistent Headache Starting as a Single Thunderclap Headache (3 New Cases)
Sheheryar A. Jamali et al.
HEADACHE (2019)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Blocking CGRP in migraine patients - a review of pros and cons
Marie Deen et al.
JOURNAL OF HEADACHE AND PAIN (2017)
The Typical Thunderclap Headache of Reversible Cerebral Vasoconstriction Syndrome and its Various Triggers
Anne Ducros et al.
HEADACHE (2016)
The Link Between Migraine, Reversible Cerebral Vasoconstriction Syndrome and Cervical Artery Dissection
Jerome Mawet et al.
HEADACHE (2016)
Wiping Out CGRP: Potential Cardiovascular Risks
Antoinette MaassenVanDenBrink et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries
Lars Edvinsson et al.
CEPHALALGIA (2010)
Inhibitory effect of BIBN4096BS, CGRP8-37, a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery
L. Edvinsson et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
分享论文
